Growth Metrics

Volitionrx (VNRX) Change in Accured Expenses (2016 - 2025)

Volitionrx filings provide 9 years of Change in Accured Expenses readings, the most recent being -$726215.0 for Q4 2025.

  • On a quarterly basis, Change in Accured Expenses rose 9.29% to -$726215.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $77977.0, a 106.41% increase, with the full-year FY2025 number at $77977.0, up 106.41% from a year prior.
  • Change in Accured Expenses hit -$726215.0 in Q4 2025 for Volitionrx, down from $993076.0 in the prior quarter.
  • In the past five years, Change in Accured Expenses ranged from a high of $1.2 million in Q4 2023 to a low of -$949636.0 in Q3 2023.
  • Median Change in Accured Expenses over the past 5 years was -$14238.5 (2022), compared with a mean of $57826.9.
  • Biggest five-year swings in Change in Accured Expenses: crashed 643.52% in 2021 and later skyrocketed 36151.57% in 2023.
  • Volitionrx's Change in Accured Expenses stood at $549403.0 in 2021, then crashed by 99.39% to $3345.0 in 2022, then skyrocketed by 36151.57% to $1.2 million in 2023, then tumbled by 166.02% to -$800624.0 in 2024, then grew by 9.29% to -$726215.0 in 2025.
  • The last three reported values for Change in Accured Expenses were -$726215.0 (Q4 2025), $993076.0 (Q3 2025), and -$560926.0 (Q2 2025) per Business Quant data.